Novel lipid compounds for lipid nanoparticle formulation and uses of the same
TW202639555APending Publication Date: 2026-10-01阿奎特斯醫療公司
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114149273
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-16
- Filing Date
- 2025-12-15
- Publication Date
- 2026-10-01
Abstract
Compounds are provided having the following Formula (I): or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein G1, G2, G3, R1, R2, R3, L1a, L2a, L1b, and L2b are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.
Need to check novelty before this filing date? Find Prior Art